Neurology Medical News about Hypnotics and Sedatives

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fospropofol: A New Sedative-Hypnotic Agent for Monitored Anesthesia Care
Annals of Pharmacotherapy, 10/22/09

Moore GD et al. – Fospropofol is a viable addition to the class of sedative–hypnotic agents due to the minimization of unwanted adverse effects of propofol and maintenance of a favorable pharmacokinetic profile facilitating sedation, anxiolysis, and rapid recovery. However, there are limited safety data to justify its use without the presence of dedicated anesthesia personnel.

<< Previous
Review: continuous positive airway pressure devices are effective...

Next >>
The Correlation and Prognostic Significance of Mgmt Promoter...

Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data
Pediatric Research, 11/09/09 Relevance Score: 45%

Is Higher ASA Class Associated With an Increased Incidence of Adverse Events During Procedural Sedation in a Pediatric Emergency Department
Pediatric Emergency Care, 10/29/09 Relevance Score: 45%

Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis
Anaesthesia, 11/11/09 Relevance Score: 44%

Nurse Reports of Adverse Events During Sedation Procedures at a Pediatric Hospital
Journal of PeriAnesthesia Nursing, 11/03/09 Relevance Score: 44%

The effect of intrathecal fentanyl on Cerebral State Index-guided sedation during spinal anaesthesia
Anaesthesia, 11/10/09 Relevance Score: 43%